{"id":371734,"title":"Notice: Multiple additions to the Prescription Drug List (PDL) [2025-02-26] - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-04-11","captureTimestamp":"2026-04-11T15:13:24.978000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2025-02-26.html","snippet":"Notice: Multiple additions to the Prescription Drug List (PDL) [2025-02-26] February 26, 2025 Our file number: 25-101236-477 The purpose of this Notice of Amendment is to notify about (1) the addition of fezolinetant, iptacopan, and zolbetuximab to the Prescription Drug List…","rawSnapshotUrl":"/api/snapshots/raw/371734","browseUrl":"https://replay.healtharchive.ca/job-6/20260411151324/https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/prescription-drug-list/notices-changes/multiple-additions-2025-02-26.html#ha_snapshot=371734","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}